Maravai LifeSciences Holdings, Inc. Accrued Liabilities, Current
Maravai LifeSciences Holdings, Inc. (MRVI) had Accrued Liabilities, Current of $30.17 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2026-08-07
- 2026-06-30: Accrued Liabilities, Current $30.17M.
- 2026-03-31: Accrued Liabilities, Current $28.65M.
- 2025-12-31: Accrued Liabilities, Current $36.57M.
- 2025-09-30: Accrued Liabilities, Current $48.14M.
| Period end | Accrued Liabilities, Current | Accrued Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $30.17M 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $28.65M 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $36.57M 10-Q · filed 2026-08-07 | |
| 2025-09-30 | $48.14M 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $50.20M 10-Q · filed 2025-08-11 | |
| 2025-03-31 | $44.60M 10-Q · filed 2025-05-12 | |
| 2024-12-31 | $39.57M 10-K · filed 2026-02-26 | $36.41M 10-K · filed 2025-03-18 |
| 2024-09-30 | $38.90M 10-K · filed 2025-03-18 | $38.50M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $40.72M 10-K · filed 2025-03-18 | |
| 2024-03-31 | $35.41M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $60.24M 10-K · filed 2025-03-18 | |
| 2023-09-30 | $56.04M 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $50.34M 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $70.06M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $53.37M 10-K · filed 2024-02-29 | |
| 2022-09-30 | $60.19M 10-Q · filed 2022-11-04 | |
| 2022-06-30 | $43.64M 10-Q · filed 2022-08-05 | |
| 2022-03-31 | $32.41M 10-Q · filed 2022-05-06 | |
| 2021-12-31 | $34.57M 10-K · filed 2023-02-28 | |
| 2021-09-30 | $31.42M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $24.79M 10-Q · filed 2021-08-11 | |
| 2021-03-31 | $28.97M 10-Q · filed 2021-05-12 | |
| 2020-12-31 | $38.55M 10-K · filed 2022-03-01 |